D. Eckland

Clinical pharmacokinetics of pioglitazone

M. Danhof, D. Eckland, 2000 .

PROactive study

G. Murray, I. Moules, M. Massi-Benedetti, 2006, The Lancet.

CAPTOPRIL: REVERSIBLE RENAL FAILURE WITH SEVERE HYPERKALÆMIA

C. Edwards, A. Grossman, D. Eckland, 1980, The Lancet.

A VariantAlkalinePhosphatasein RenalCell Carcinoma

H. Hodgson, S. Saverymuttu, D. Eckland, 2004 .

Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.

Z. Ram, J. Martin, M. Westphal, 2013, The Lancet. Oncology.

A variant alkaline phosphatase in renal cell carcinoma.

D. Moss, S. Saverymuttu, D. Eckland, 1982, Clinical chemistry.

A preclinical assessment of the safety and biodistribution of an adenoviral vector containing the herpes simplex virus thymidine kinase gene (Cerepro®) after intracerebral administration

S. Yla-Herttuala, G. Langford, D. Eckland, 2009, The journal of gene medicine.